Gilde Healthcare Partners, a specialized healthcare investor, led a $45m Series C funding in GT Medical Technologies, a medical device company, with participation from MVM Partners, MedTech Venture Partners, and BlueStone Venture Partners. "Our focus is making state-of-the-art medical advancements like GammaTile more available to patients to address unmet clinical needs and ultimately improve the standard of care. It's gratifying to know that we're enabling GT Medical Technologies to improve the lives of more patients with brain tumors," Geoff Pardo, Gilde Healthcare Partners General Partner.